Compare WVE & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | ARRY |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | Singapore | United States |
| Employees | 317 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 975.3M |
| IPO Year | 2015 | 2020 |
| Metric | WVE | ARRY |
|---|---|---|
| Price | $6.04 | $5.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 19 |
| Target Price | ★ $29.81 | $10.21 |
| AVG Volume (30 Days) | 2.2M | ★ 7.2M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.56 |
| EPS | N/A | ★ N/A |
| Revenue | $3,704,000.00 | ★ $1,284,141,000.00 |
| Revenue This Year | N/A | $15.72 |
| Revenue Next Year | $85.67 | $8.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 149.43 | 40.22 |
| 52 Week Low | $5.02 | $4.77 |
| 52 Week High | $21.73 | $12.23 |
| Indicator | WVE | ARRY |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 39.92 |
| Support Level | $5.49 | $4.77 |
| Resistance Level | $6.21 | $8.17 |
| Average True Range (ATR) | 0.25 | 0.40 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 83.54 | 36.31 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.